Riskpilot← Back to searchSign inGet full accessMuntra AB
ABActiveOrg 5569352726Narvavägen 12Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201313 employees
Revenue 2024
SEK 22,7M
+41% vs 2023
EBITDA margin
-9.4%
+43% vs 2023
Equity ratio
77.0%
Financial strength
Net profit 2024
SEK -3M
+33% vs 2023
| Revenue | SEK 22,7M | +41% |
| EBITDA | SEK -2,1M | +43% |
| Net profit | SEK -3M | +33% |
| Total assets | SEK 22,3M | +97% |
| Equity | SEK 17,2M | +120% |
| Employees | 13 | — |
Legal name
Muntra AB
Org number
5569352726
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25 juni 2013
Share capital
SEK 105 109
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Rask-Andersen, Niels Helge Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva mjukvaruutveckling och erbjuda tjänster för tandvård, övrig humanvård, djurvård samt därmed förenlig verksamhet.
Address
Narvavägen 12
Phone
+46840906890
Email
pontus@muntra.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 2 091 | 2 657 | 3 128 | 4 629 | 9 111 | 16 108 | 22 660 |
| Staff expenses | — | — | — | — | — | — | — | −5 872 | −9 493 | −11 102 |
| EBITDA | −124 | −785 | −23 | −557 | −417 | 417 | −777 | −3 301 | −3 744 | −2 127 |
| Depreciation & amort. | −0 | −453 | −453 | −723 | −792 | −885 | −873 | −639 | −847 | −1 033 |
| EBIT | −124 | −1 238 | −476 | −1 280 | −1 209 | −468 | −1 650 | −3 940 | −4 591 | −3 161 |
| Net financials | −7 | −69 | −28 | −56 | −13 | −5 | −1 | 17 | 30 | 113 |
| Profit before tax | −131 | −1 308 | −503 | −1 336 | −1 222 | −473 | −1 652 | −3 923 | −4 561 | −3 047 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — | — |
| Net profit | −131 | −1 308 | −503 | −1 336 | −1 222 | −473 | −1 652 | −3 923 | −4 561 | −3 047 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 754 | 3 348 | 4 180 | 3 182 | 2 495 | 3 052 | 8 910 | 15 327 | 11 311 | 22 304 |
| Equity | 655 | 2 229 | 2 907 | 2 245 | 1 568 | 1 645 | 7 071 | 12 363 | 7 802 | 17 175 |
| Long-term debt | 500 | 479 | 604 | 303 | 219 | 169 | 0 | — | — | — |
| Short-term debt | 599 | 640 | 669 | 633 | 708 | 1 239 | 1 840 | 2 964 | 3 509 | 5 129 |
| Total debt | 1 099 | 1 119 | 1 273 | 936 | 927 | 1 408 | 1 840 | 2 964 | 3 509 | 5 129 |
EBITDA margin
-9.4%
This company
15.8%
Market median
-159% vs market
20152024
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
20152024
Return on equity
-17.7%
This company
18.4%
Market median
-196% vs market
20152024
Net profit margin
-13.4%
This company
8.1%
Market median
-265% vs market
20152024
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20152024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CM Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
YM | Audit | 2022 | — | — |
AO Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Muntra AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Michael Pontus Green | Chief Executive Officer | 0 companies |
| Ylva Marie Ekmark Tjärnberg | Audit | 0 companies |
| Anders Oskar Hettinger | Chief Auditor | 0 companies |
| Sven Lennart Svantesson | Board of Directors | 0 companies |
| Per Gustaf Vilhelm Granath | Board of Directors | 0 companies |
| Per Lennart Tjernberg | Chairman | 0 companies |
| Ebba Signe Elisabet Sjöstrand | Board of Directors | 0 companies |
| Linus Peter Liungman Bosaeus | Board of Directors | 0 companies |
| Niels Helge Rask-Andersen | Board of Directors | 0 companies |
| Josef Peter Bexell | Board of Directors | 0 companies |